CoChat

Frataxin and Mitochondrial Carrier Proteins, Mrs3p and Mrs4p, Cooperate in Providing Iron for Heme Synthesis

Open access
Zhang, Yan, Lyver, Elise R., Knight, Simon A.B., Lesuisse, Emmanuel, Dancis, Andrew · 2005 · Journal of Biological Chemistry
Cited by 111

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Frataxin is a conserved mitochondrial protein implicated in cellular iron metabolism. Deletion of the yeast frataxin homolog (YFH1) was combined with deletions of MRS3 and MRS4, mitochondrial carrier proteins implicated in iron homeostasis. As previously reported, the Δyfh1 mutant accumulated iron in mitochondria, whereas the triple mutant (ΔΔΔ) did not. When wild-type, Δmrs3/4, Δyfh1, and ΔΔΔ strains were incubated anaerobically, all strains were devoid of heme and protected from iron and oxygen toxicity. The cultures were then shifted to air for a short time (4–5 h) or a longer time (15 h), and the evolving mutant phenotypes were analyzed (heme-dependent growth, total heme, cytochromes, heme proteins, and iron levels). A picture emerges from these data of defective heme formation in the mutants, with a markedly more severe defect in the ΔΔΔ than in the individual Δmrs3/4 or Δyfh1 mutants (a “synthetic” defect in the genetic sense). The defect(s) in heme formation could be traced to lack of iron. Using a real time assay of heme biosynthesis, porphyrin precursor and iron were presented to permeabilized cells, and the appearance and disappearance of fluorescent porphyrins were followed. The Mrs3/4p carriers were required for rapid iron transport into mitochondria for heme synthesis, whereas there was also evidence for an alternative slower system. A different role for Yfh1p was observed under conditions of low mitochondrial iron and aerobic growth (revealed in the ΔΔΔ), acting to protect bioavailable iron within mitochondria and to facilitate its use for heme synthesis. Frataxin is a conserved mitochondrial protein implicated in cellular iron metabolism. Deletion of the yeast frataxin homolog (YFH1) was combined with deletions of MRS3 and MRS4, mitochondrial carrier proteins implicated in iron homeostasis. As previously reported, the Δyfh1 mutant accumulated iron in mitochondria, whereas the triple mutant (ΔΔΔ) did not. When wild-type, Δmrs3/4, Δyfh1, and ΔΔΔ strains were incubated anaerobically, all strains were devoid of heme and protected from iron and oxygen toxicity. The cultures were then shifted to air for a short time (4–5 h) or a longer time (15 h), and the evolving mutant phenotypes were analyzed (heme-dependent growth, total heme, cytochromes, heme proteins, and iron levels). A picture emerges from these data of defective heme formation in the mutants, with a markedly more severe defect in the ΔΔΔ than in the individual Δmrs3/4 or Δyfh1 mutants (a “synthetic” defect in the genetic sense). The defect(s) in heme formation could be traced to lack of iron. Using a real time assay of heme biosynthesis, porphyrin precursor and iron were presented to permeabilized cells, and the appearance and disappearance of fluorescent porphyrins were followed. The Mrs3/4p carriers were required for rapid iron transport into mitochondria for heme synthesis, whereas there was also evidence for an alternative slower system. A different role for Yfh1p was observed under conditions of low mitochondrial iron and aerobic growth (revealed in the ΔΔΔ), acting to protect bioavailable iron within mitochondria and to facilitate its use for heme synthesis. Frataxin is a mitochondrial protein, the deficiency of which has been implicated in the human disease Friedreich's ataxia (1Campuzano V. Montermini L. Molto M.D. Pianese L. Cossee M. Cavalcanti F. Monros E. Rodius F. Duclos F. Monticelli A. Science. 1996; 271: 1423-1427Crossref PubMed Scopus (2323) Google Scholar). This is a progressive disease in which specialized tissues (neurons of dorsal root ganglia, cardiac muscle cells, and pancreatic beta cells) undergo mitochondrial degeneration and cell death (2Puccio H. Simon D. Cossee M. Criqui-Filipe P. Tiziano F. Melki J. P. M. PubMed Scopus Google Scholar). A to iron has been the of a yeast for the yeast frataxin homolog (YFH1) M. D. Montermini L. M. J. Science. PubMed Scopus Google Scholar). yeast iron in mitochondria E. A. PubMed Scopus Google the iron proteins, and heme proteins, or E. A. PubMed Scopus Google A. D. A. P. PubMed Scopus Google Scholar). The iron in mitochondria of the phenotypes of the frataxin mutant to be of to proteins, and D. PubMed Scopus Google PubMed Scopus Google Scholar). to the of frataxin be the to of lack of frataxin from Frataxin has a conserved and M. J. PubMed Google A. PubMed Scopus Google and yeast E. A. Scopus Google been and The a of or and in a with a and a the The of frataxin in of in and phenotypes of formation M. Scopus Google M. Science. PubMed Scopus Google heme E. A. PubMed Scopus Google A. D. A. P. PubMed Scopus Google A. E. PubMed Scopus Google and iron J. PubMed Scopus Google been of within mitochondria to an role in frataxin and with J. PubMed Scopus Google M. Science. PubMed Scopus Google and E. A. PubMed Scopus Google J. PubMed Scopus Google been is a protein an in J. PubMed Scopus Google J. PubMed Scopus Google and a role of frataxin in has been M. Scopus Google J. A. PubMed Scop

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m500397200

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Zhang, Y., Lyver, E. R., Knight, S. A. B., Lesuisse, E., & Dancis, A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-05
Volume
280
Issue
20
Pages
19794-19807
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2107386134
Cited by
111
References
13
FWCI
4.38
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.